期刊文献+

荧光定量PCR法检测MDM2 T309G位点多态性 被引量:1

Novel real-time PCR methods for clinical detection of MDM2 T309G polymorphism
暂未订购
导出
摘要 目的建立一种简便易行的MDM2基因单核苷酸多态性(SNP)309位点的检测方法。方法用DNA提取试剂盒提取外周血DNA,建立MDM2 SNP309位点荧光定量PCR熔解曲线检测法。应用煮沸法处理血样取得粗制DNA,行荧光定量PCR检测,建立位点特异引物法检测MDM2 SNP309位点基因型。比较静置不同时间、反复冻融等处理以及存在血液学指标异常的血样经煮沸法提取DNA对荧光定量PCR扩增反应的影响,通过观察PCR扩增情况,评估不同处理方法对PCR扩增反应的影响。结果荧光定量建立MDM2 SNP309位点PCR检测方法。煮沸法提取的DNA可用于普通PCR、荧光定量PCR扩增体系,且煮沸法处理血样具有较广的适用范围。结论采用MDM2基因SNP309位点特异性引物行荧光定量PCR检测法是一种简便易行的MDM2基因SNP309位点检测方法,该方法有较好的临床适用性。 Objective To establish a simple,convenient method for genotyping of MDM2 SNP309.Methods Using SYBR GREEN PCR with Tm-shift primers and genomic DNA purified with TIANamp DNA blood kit,we established a new method to detect genotyping of MDM2 SNP309.And we also genotyped MDM2 SNP309 by SYBR GREEN PCR with Tm-shift primers using whole blood DNA extracted by boiling method.Furthermore,genomic DNA were purified using boiling method from different blood samples kept at room temperature for different time or treated with multiple freezing and thawing as well as hematologic abnormal blood samples.Quantitative PCR were carried out to observe the amplification efficiency of the obtained DNA templates to assess the DNA extraction method.Results We established a novel,SYBR GREEN PCR method for MDM2 SNP309 genotyping.DNA purified by both methods mentioned before were suitable for MDM2 SNP309 SYBR GREEN PCR.DNA extracted using boiling method could be used for polymerase chain reaction even when the blood sample were disposed in different ways.Conclusion In the present research,we established methods for MDM2 SNP309 genotype.Boiling method for DNA extraction is proved to be a simpler and quicker way of processing whole-blood samples compared with the DNA templates,and is effective for both PCR-RFLP and SYBR GREEN PCR.
出处 《临床肿瘤学杂志》 CAS 2011年第7期577-581,共5页 Chinese Clinical Oncology
基金 国家自然科学基金资助项目(200803150007)
关键词 MDM2 SNP PCR 临床检测 肿瘤标志物 MDM2 SNP PCR Clinical testing Tumor biomarker
  • 相关文献

参考文献10

  • 1程钢,何蕴韶,周新宇.荧光定量聚合酶链反应检测乙型肝炎病毒[J].中华医学检验杂志,1999,22(3):135-138. 被引量:387
  • 2Xiao M,Zhang L,Zhu X,et al.Genetic polymorphisms ofMDM2 and TP53 genes are associated with risk of nasopharyngealcarcinoma in a Chinese population. BMC Cancer . 2010
  • 3Akkiz H,,Smbl AT,Bayram S,et al.MDM2 promoter poly-morphism is associated with increased susceptibility to hepatocel-lular carcinoma in Turkish population. Cancer Epidemiol . 2010
  • 4Onat,OE,Tez,M,Ozcelik,T,Toruner,GA.MDM2 T309G polymorphism is associated with bladder cancer. Anticancer Research . 2006
  • 5Liu W,He L,Ramirez J,Ratain MJ.Interac-tions between MDM2 and TP53 Genetic Alterations,and Their Impact on Response to MDM2 Inhibitors andOther Chemotherapeutic Drugs in Cancer Cells. Clinical Cancer Research . 2009
  • 6Nayak MS,Yang JM,Hait WN.Effect of a single nucleotide polymorphism in the murine double minute 2 promoter (SNP309) on the sensitivity to topoisomerase II-targeting drugs. Cancer Research . 2007
  • 7Hu Z,Jin G,Wang L,Chen F,Wang X,Shen H.MDM2promoter polymorphism SNP309contributes to tumor susceptibility:evidence from21case-control studies. Cancer Epidemiology Biomarkers and Prevention . 2007
  • 8Rayburn E,Zhang R,He J,et al.MDM2 and human malignancies: expression,clinical pathology,prognostic markers,and implications for chemotherapy. Cur Cancer Drug Targets . 2005
  • 9Kondo,S,Kondo,Y,Hara,H,Kaakaji,R,Peterson,JW,Morimura,T,Takeuchi,J,Barnett,GH.Mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line. British Journal of Cancer . 1996
  • 10Tu HF,,Chen HW,Kao SY,Lin SC,Liu CJ,Chang KW.MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiotherapy and Oncology . 2008

二级参考文献1

  • 1Chen C H,J Virol Methods,1995年,53卷,131页

共引文献386

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部